Nearly three years ago, I asked in a blog post for The Beacon whether the new Biden Administration would accomplish the seemingly impossible task of lowering insulin prices. At the time, President Biden was more so focused on re-instating components of the Affordable Care Act undone during the Trump Administration.
Many were upset with President Biden for not forcing insulin producers to lower their prices. I disagreed, arguing that the repeated failures of numerous administrations to make insulin cheaper strongly implied more political action is a lost cause in pursuit of lowering drug prices. However, at the end of the post, I wrote, “President Biden will eventually face
